Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1982;16(3):257-64.
doi: 10.1007/BF00343314.

Resistance to cell-mediated cytotoxicity is correlated with reduction of H-2K gene products in AKR leukemia

Resistance to cell-mediated cytotoxicity is correlated with reduction of H-2K gene products in AKR leukemia

W Schmidt et al. Immunogenetics. 1982.

Abstract

AKR leukemia cell lines differing in the amount of H-2K and H-2D antigens expressed on the cell surface were used to assess cell-mediated immune responses in syngeneic mice against Gross/AKR murine leukemia virus (MuLV)-induced tumors. Leukemic cells with reduced expression of H-2Kk antigens were inactive as inducers of Gross-MuLV/H-2k-specific cytotoxic T lymphocytes (CTL) and resistant to lysis by CTL raised against H-2Kk positive AKR leukemia cells. H-2Kk positive leukemias induced cytotoxic effectors, which upon restimulation in vitro, lysed the stimulating and other H-2Kk positive leukemia cells. In antibody inhibition experiments, T-cell-mediated cytotoxicity to these leukemias could only be inhibited by antisera and monoclonal antibodies specific for the H-2Kk antigens. Due to this specific role of H-2Kk antigens in T-cell cytotoxicity to Gross/AKR MuLV-induced tumors, reduced expression of H-2Kk antigens on spontaneous AKR leukemic cells could have important implications for surveillance of these neoplastic cells.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Immunogenet. 1980 Feb;7(1):19-29 - PubMed
    1. Cancer Res. 1981 Nov;41(11 Pt 2):4752-66 - PubMed
    1. J Immunol. 1980 Jun;124(6):2845-53 - PubMed
    1. J Immunol. 1980 Feb;124(2):533-40 - PubMed
    1. Proc Natl Acad Sci U S A. 1980 May;77(5):2923-6 - PubMed

Publication types